PHVS Pharvaris N.V. Insider Trading

CMO Lu Peng sells 18,733 shares at blended avg $30.21 for $565,859.27; holdings drop to 66,083 shares (-22.1%)

Lu Peng, Chief Medical Officer of Pharvaris N.V., executed 2 separate sales totaling 18,733 shares for $565,859.27 on April 29-30, 2026, at a blended average price of $30.21. The transaction reduced his holdings by 22.1%, from 84,816 shares to 66,083 shares post-transaction. The sales occurred at prices slightly above the current market price of $29.44, and within the 52-week range of $15.46–$31.01, approaching the 52-week high of $31.01. No prior trading history, scheduled trading plan disclosure, or circumstantial flags are referenced, leaving the motivation opaque.

Lesage Anne (Chief Early Development) at Pharvaris sold 48,300 shares for $1,459,970.16 across 5 transactions at blended average $30.23

Anne Lesage, Chief Early Development at Pharvaris, executed 5 separate sales totaling 48,300 shares for $1,459,970.16 between April 29–30, 2026, at a blended average price of $30.23. Her post-transaction holdings of 133,969 shares represent a 26.5% reduction from pre-transaction levels of 182,269 shares. The sales occurred near the 52-week high of $31.01, with the current price at $29.44 representing a 5.1% pullback from that peak. The multi-day execution and varied price points (ranging from $30.06 to $30.26) across substantial volume warrant review of her prior trading patterns and any regulatory disclosures regarding the motivation and timing of these transactions.

Pharvaris CEO Modig Berndt sells 23,333 shares for $647,281.38; holdings reduced to 142.1K shares (-14.1%)

Modig Berndt executed two separate sales totaling 23,333 shares for $647,281.38, reducing his post-transaction holdings to 142.1K shares (a 14.1% decrease from pre-transaction holdings of 165.4K shares). The transactions occurred at blended average price of $27.74, which is above the current market price of $26.63 and near the 52-week high of $29.45. The stock has declined 2.9% over the past 30 days and is trading 9.6% below its 52-week high, though it has risen 2.9% over the past 90 days. As the CEO, this material reduction in holdings represents a significant portion of executive equity and warrants investor attention regarding his continued commitment to the company.